Atlas Trials

Safety Study of XL844 in Subjects With Chronic Lymphocytic Leukemia

Clinical trial NCT00234481 · TERMINATED

Trial details

NCT number
NCT00234481
Sponsor
Exelixis
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.